“…Many of the barriers to guideline adherence and patient receipt of genetic counseling that were found during the ES were previously reported in the literature and support the existence and prevalence of these barriers in clinical cancer genetics settings. These barriers included inconsistent or lack of referral for genetics services from a medical provider or physician, lack of knowledge dissemination to medical providers or physicians regarding guidelines for genetics referral or testing, and perceived or real lack of genetic counseling appointment availability (Brown, Hutchison, Zinberg, & McGovern, 2005; Burgess, Carmany, & Trepanier, 2016; Calzone et al, 2005; Chun et al, 2016; Cragun et al, 2015; Delikurt, Williamson, Anastasiadou, & Skirton, 2015; Demsky et al, 2013; Douma, Smets, & Allain, 2016; Eichmeyer, Burnham, Sproat, Tivis, & Beck, 2014; Elnahal, Clancy, & Shulkin, 2017; Hamilton et al, 2016; Kinney et al, 2014; Macdonald et al, 2012; McCarthy et al, 2016; Nair et al, 2017; Ridge et al, 2009; Schwartz et al, 2014; Sperber et al, 2016; Stuckey et al, 2014; Sussner, Jandorf, & Valdimarsdottir, 2011; Vadaparampil, Scherr, Cragun, Malo, & Pal, 2015; Willis et al, 2016).…”